Results 151 to 160 of about 213,915 (375)

Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Glucose monitoring is increasingly based on continuous glucose monitoring (CGM) systems. However, data on the accuracy of CGM within the hypoglycaemic range is sparse. This study investigated CGM accuracy within the hypoglycaemic range in three different clinical settings of hypoglycaemia.
Lukas van Baal, Lorenz Raess, Annie Mathew, Harald Lahner, Nicole Unger, Dagmar Fuhrer   +5 more
wiley   +1 more source

Utility of Adrenal Vein Sampling With and Without Ultra‐Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism

Endocrinology, Diabetes & Metabolism
Background Adrenal vein sampling (AVS), integral to identifying surgically remediable unilateral primary aldosteronism (PA), is technically challenging and subject to fluctuations in cortisol and aldosterone secretion.
Christopher A. Preston, Eric X. Z. Yong, Benjamin Marginson, Stephen G. Farrell, Matthew P. Sawyer, Hikaru Hashimura, Maresa M. Derbyshire, Richard J. MacIsaac, Nirupa Sachithanandan   +8 more
doaj   +1 more source

Basal and Post-ACTH Aldosterone and Its Ratios Are Useful During Adrenal Vein Sampling in Primary Aldosteronism.

Journal of Clinical Endocrinology and Metabolism, 2016
Nada El Ghorayeb, T. L. Mazzuco, I. Bourdeau, Jean-Philippe Mailhot, Ping Zhu, É. Thérasse, A. Lacroix   +6 more
semanticscholar   +1 more source

EEG functional connectivity as a marker of evolution from infantile epileptic spasms syndrome to Lennox–Gastaut syndrome

Epilepsia, EarlyView.
Abstract Objective Timely diagnosis and effective treatment of Lennox–Gastaut syndrome (LGS) improve prognosis and lower health care costs, but the transition from infantile epileptic spasms syndrome (IESS) to LGS is highly variable and insidious. Objective biomarkers are needed to monitor this progression and guide clinical decision‐making. Methods We
Blanca Romero Milà, Virginia B. Liu, Rachel J. Smith, Derek K. Hu, Natalie A. Benneian, Shaun A. Hussain, Maija Steenari, Donald Phillips, David Adams, Clare Skora, Beth A. Lopour, Daniel W. Shrey   +11 more
wiley   +1 more source

The use of TES-therapy in complex the treatment of stable angina II-III functional class

Кубанский научный медицинский вестник, 2016
The article is devoted to the application of TES-therapy in the complex treatment of angina pectoris II-III functional class. To assess the efficacy of treatment was assessed cytokine status (IL-1β, IL-4, IL-6, IL-10) and hormonal profile (cortisol, ACTH,
E. K. Gordeeva, A. H. Kade
doaj  

ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long‐term follow‐up of 519 patients in two large European centres [PDF]

, 2016
Michael O’Reilly, Raoul C. Reulen, Saket Gupta, Claire A. Thompson, Rosemary Dineen, Eirena L. Goulden, Gabriella Bugg, Harriet Pearce, Andy Toogood, Neil Gittoes, Rosalind Mitchell, Christopher J. Thompson, John Ayuk   +12 more
openalex   +1 more source

60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH.

Journal of Molecular Endocrinology, 2016
N. Gallo‐Payet
semanticscholar   +1 more source

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

Equine Veterinary Education, EarlyView.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess, A. Bracken, S. Rao, Y. Nout‐Lomas, D. Gustafson, L. Bass   +5 more
wiley   +1 more source

Plasma ACTH concentration and pituitary gland histo-pathology in rats infected with

, 2018
Charles Irungu Maina
openalex   +2 more sources

Update on diagnosis, nonpharmacological treatment and prevention of Equine Gastric Ulcer Syndrome (EGUS)

Equine Veterinary Education, EarlyView.
Summary The term Equine Gastric Ulcer Syndrome (EGUS) has been used since 1999. As there are important differences, the terms Equine Squamous Gastric Disease (ESGD) and Equine Glandular Gastric Disease (EGGD) were introduced in 2015. Risk factors like dietary management, training regimens and drug side effects, as described for NSAIDs, predispose ...
R. Lensing, A. K. Barton
wiley   +1 more source